Updated: Minute Insight: FDA Clears Zimmer Biomet’s Identity Shoulder, ZB Calls It ‘Biggest Shoulder Launch In the Last Five Years’
Executive Summary
Zimmer Biomet said on 20 September that the FDA cleared its Identity shoulder system and expects it to be available to US surgeons in the fourth quarter.
You may also be interested in...
AAOS 2022 Roundup: Stryker, Zimmer Biomet, J&J’s DePuy Synthes, Canary Medical
In this first of two roundups, Medtech Insight highlights new product launches and technologies showcased at the annual AAOS conference by three major orthopedics players and medical data company Canary Medical.
Minute Insight: Smith + Nephew Expands VR-based Surgical Training
Smith + Nephew is expanding its suite of simulation technologies to train surgeons on new techniques before they enter the operating room.
BTIG Analyst Zooms Into Alcon’s Revamp Into ‘Building A Pharma Company Inside A Device Company’
In his recent report on Alcon, BTIG analyst Ryan Zimmerman estimated that its pharmaceutical portfolio could generate close to $900m in fiscal year 2022.